Previous studies have shown that RUNX1 transcription factors associate with co-activators CBP and p300 [21], whereas leukemia-associated RUNX1-ETO proteins do not interact with CBP/p300 family proteins, but rather with co-repressive proteins including HDACs. The gene discussed is RUNX1; the disease is leukemia.